CND Life Sciences, Beth Israel Ink Licensing Deal for Neurodegenerative Disease Test Technology
The agreement gives CND access to technologies key to CND's skin biopsy-based test for the hallmarks of the synucleinopathy family of neurodegenerative diseases.
Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic
The collaboration will expand Qiagen's NGS testing portfolio for precision medicine beyond oncology into neurology applications.
UK Startup ESP Diagnostics Eyes 2023 Launch for Early-Stage Parkinson's, Lewy Body Dementia Test
To accelerate diagnostic development, the Newcastle-based firm recently snagged a £272,000 Innovate UK grant.
Amprion Wins Additional $730K NIH Grant to Validate Parkinson's Disease Test
The recently launched test is designed to detect a-synuclein aggregates to aid in the diagnosis of Parkinson's disease and other brain conditions.
The firm obtained FDA breakthrough device designation in 2019 for its protein misfolding cyclic amplification technology and SynTap assay.
Nov 2, 2021
Valted Seq Raises $10.5M Seed Funding
Jul 17, 2019
Aug 15, 2018
Sep 15, 2017